Your browser doesn't support javascript.
loading
Evaluation of Anti-Neuroinflammatory Activity of Isatin Derivatives in Activated Microglia.
Cenalmor, Alejandro; Pascual, Elena; Gil-Manso, Sergio; Correa-Rocha, Rafael; Suárez, José Ramón; García-Álvarez, Isabel.
Afiliación
  • Cenalmor A; Facultad de Ciencias Experimentales, Universidad Francisco de Vitoria, Pozuelo de Alarcón, 28223 Madrid, Spain.
  • Pascual E; Facultad de Ciencias Experimentales, Universidad Francisco de Vitoria, Pozuelo de Alarcón, 28223 Madrid, Spain.
  • Gil-Manso S; Laboratory of Immune-Regulation, Gregorio Marañón Health Research Institute (IISGM), 28009 Madrid, Spain.
  • Correa-Rocha R; Laboratory of Immune-Regulation, Gregorio Marañón Health Research Institute (IISGM), 28009 Madrid, Spain.
  • Suárez JR; Departamento de Química en Ciencias Farmacéuticas, Facultad de Farmacia, Universidad Complutense de Madrid, 28040 Madrid, Spain.
  • García-Álvarez I; Facultad de Ciencias Experimentales, Universidad Francisco de Vitoria, Pozuelo de Alarcón, 28223 Madrid, Spain.
Molecules ; 28(12)2023 Jun 20.
Article en En | MEDLINE | ID: mdl-37375437
ABSTRACT
Neuroinflammation plays a crucial role in the progression of Alzheimer's disease and other neurodegenerative disorders. Overactivated microglia cause neurotoxicity and prolong the inflammatory response in many neuropathologies. In this study, we have synthesised a series of isatin derivatives to evaluate their anti-neuroinflammatory potential using lipopolysaccharide activated microglia as a cell model. We explored four different substitutions of the isatin moiety by testing their anti-neuroinflammatory activity on BV2 microglia cells. Based on the low cytotoxicity and the activity in reducing the release of nitric oxide, pro-inflammatory interleukin 6 and tumour necrosis factor α by microglial cells, the N1-alkylated compound 10 and the chlorinated 20 showed the best results at 25 µM. Taken together, the data suggest that 10 and 20 are promising lead compounds for developing new neuroprotective agents.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Fármacos Neuroprotectores / Isatina Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Fármacos Neuroprotectores / Isatina Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article